Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
As Crouse wrote, “The State of the Nation could be summed up in one fact from the South African Reserve Bank (SARB), namely ...